Sedative-hypnotics represent a significant clinical challenge across modern surgical pathways. While clinical guidelines explicitly discourage acute premedication in older adults, chronic preoperative benzodiazepine use remains highly prevalent yet poorly characterized. Many patients take these medications daily for chronic insomnia, anxiety disorders, or muscle spasms. Consequently, surgical teams often face substantial uncertainty regarding how baseline sedative regimens influence surgical recovery. A comprehensive scoping review has now mapped the global literature to clarify these crucial clinical associations and identify vital research gaps.

Evaluating Chronic Preoperative Benzodiazepine Use Across Surgical Populations

Benzodiazepines augment inhibitory gamma-aminobutyric acid neurotransmission within the central nervous system. While clinicians readily recognize the transient sedative consequences of acute single doses, prolonged daily exposure produces significant neurobiological tolerance and physical dependence. Historically, surgical safety research prioritized acute premedication hazards, including delayed post-anesthesia recovery and emergence agitation. Nevertheless, millions of patients globally receive chronic outpatient prescriptions of lorazepam, clonazepam, and alprazolam for non-surgical indications. When these patients present for elective or emergency operations, perioperative teams must navigate intricate pharmacodynamic interactions. Furthermore, surgical trauma incites systemic inflammatory cascades and metabolic alterations that magnify central nervous system vulnerability. Abruptly withdrawing these medications on the morning of surgery risks severe withdrawal, autonomic hyperactivity, and seizures. Conversely, unadjusted maintenance may prolong cognitive recovery and potentiate anesthetic-induced neurotoxicity. Because standardized perioperative guidelines for long-term sedative therapy remain scarce, clinical practice varies substantially across surgical institutions.

Scoping Review Findings and Definition Heterogeneity

To systematically evaluate the published literature, investigators conducted an extensive scoping review across five major biomedical databases. The authors preregistered their protocol with the Open Science Framework to ensure methodological transparency and rigor. Furthermore, independent reviewers screened thousands of citations in duplicate to isolate studies assessing adult surgical cohorts with established sedative use. Ultimately, the synthesis incorporated 130 clinical studies encompassing diverse surgical procedures. Most included reports were observational cohort studies, and over three-quarters evaluated benzodiazepines merely as secondary confounding variables. Importantly, the review identified striking heterogeneity in exposure definitions. Criteria for chronicity ranged from thirty days to an entire year of documented use prior to surgical intervention. Furthermore, nearly forty-eight percent of the included studies failed to provide any systematic definition for chronic exposure duration. This marked variability severely impairs clinicians from comparing outcomes or synthesizing pooled risk estimates across published datasets.

Postoperative Opioid Escalation and Synergistic Central Depression

Among all evaluated clinical outcomes, postoperative opioid utilization was the most frequently studied domain, appearing in over forty percent of the literature. Importantly, the review highlighted a consistent and troubling association between baseline sedative therapy and elevated postoperative opioid consumption. Patients taking chronic benzodiazepines consistently required substantially higher daily and cumulative morphine milligram equivalents after surgery. In addition, these individuals demonstrated a significantly increased probability of developing persistent, long-term opioid use beyond ninety days postoperatively. Pharmacologically, co-administering opioids and benzodiazepines creates dangerous synergy by depressing respiratory drive and central brainstem reflexes. Furthermore, chronic sedative exposure frequently correlates with baseline psychological distress and hyperalgesia, which heightens postoperative pain sensitivity. Consequently, patients require more rescue analgesia, which inadvertently delays hospital discharge and elevates readmission rates. Perioperative teams must anticipate this increased analgesic need and proactively implement multimodal, opioid-sparing pain management strategies.

Delirium and Acute Postoperative Neurocognitive Disorders

Postoperative delirium and cognitive impairment represented the second most common outcome domain identified in the review. Nearly fifteen percent of the included investigations examined neurocognitive deficits, with most studies reporting unfavorable outcomes linked to baseline benzodiazepine use. Delirium is a serious neuropsychiatric complication characterized by acute inattention, disorientation, and fluctuating consciousness. In geriatric surgical patients, chronic sedative therapy depletes cognitive reserve and alters normal neurochemical equilibrium. Furthermore, sustained gamma-aminobutyric acid receptor stimulation impairs neural connectivity during recovery from general anesthesia. When operative trauma triggers systemic neuroinflammation, vulnerable neural networks rapidly decompensate. Consequently, affected individuals experience prolonged intensive care unit stays, heightened risk of permanent dementia, and increased perioperative mortality. Although acute premedication guidelines discourage one-off doses in older adults, chronic exposure likely poses an even greater risk of postoperative cognitive dysfunction.

Evidence Limitations and Perioperative Clinical Stewardship

While this scoping review consolidates an extensive body of literature, several methodological limitations warrant consideration. Because scoping reviews map existing literature without formal quality assessments, these findings illustrate clinical associations rather than proven causal relationships. Furthermore, confounding by indication remains a prominent challenge across observational designs. Patients receiving chronic sedatives frequently carry concurrent burdens of major depression, generalized anxiety, or chronic pain syndromes, which independently impair recovery. Additionally, few investigations stratified risks by drug half-life or specific daily dosing. Nevertheless, perioperative clinicians can adopt practical stewardship strategies to mitigate patient harm. Clinicians must conduct rigorous preoperative medication reconciliation to identify chronic exposure early. Surgical teams should continue baseline maintenance doses to prevent life-threatening withdrawal while avoiding supplemental acute premedication. Furthermore, utilizing processed electroencephalography and regional analgesia protects vulnerable brains during surgery.

Frequently Asked Questions

Why is chronic preoperative benzodiazepine use linked to higher opioid consumption?

Chronic benzodiazepine exposure alters central inhibitory pathways and frequently exacerbates underlying pain sensitivity through central sensitization mechanisms. Additionally, patients taking long-term sedatives often experience coexisting anxiety and mood disorders, which can amplify subjective surgical pain perception. Consequently, these individuals require larger cumulative doses of rescue opioids postoperatively, substantially increasing their risk of prolonged opioid dependence and sedation-related adverse events during clinical recovery.

Should surgical patients abruptly stop chronic benzodiazepines before an operation?

Healthcare providers should never advise patients to abruptly stop chronic benzodiazepine therapy immediately prior to surgery. Sudden discontinuation risks precipitating acute withdrawal, which manifests as severe sympathetic hyperactivity, delirium, tremors, and life-threatening seizures. Instead, clinicians should maintain the patient's baseline daily dose throughout the surgical admission, while strictly avoiding redundant acute sedative premedication or unmonitored intraoperative boluses that impair neurological recovery.

What perioperative measures reduce delirium risk in chronic benzodiazepine users?

Anesthesia providers can reduce neurocognitive risks by utilizing depth-of-anesthesia monitoring to prevent excessive general anesthetic exposure and avoiding supplemental sedative premedication. Furthermore, incorporating regional anesthesia techniques and non-opioid multimodal analgesics significantly lowers systemic opioid needs. Postoperatively, clinical teams should institute structured non-pharmacological delirium bundles, emphasizing early mobilization, cognitive orientation, sensory aids, and optimal sleep hygiene during postoperative hospital inpatient care.

Disclaimer: This content is for informational and educational purposes only and should not be considered as medical advice. Healthcare professionals should make decisions based on their clinical judgment and the individual patient presentation. Refer to the latest local and national guidelines for clinical practice.

References

1. Nurse R et al. Chronic preoperative benzodiazepine use and perioperative outcomes: a scoping review. Br J Anaesth. 2026 Nov 09. doi: undefined. PMID: 43003743.
2. Young J, He H, Saud H, et al. Effect of perioperative benzodiazepine use on intraoperative awareness and postoperative delirium: a systematic review and meta-analysis of randomised controlled trials and observational studies. Br J Anaesth. 2023;131(2):302-313.
3. Wright JD, Chen L, Suzuki Y, et al. Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use. JAMA Netw Open. 2021;4(6):e2112478.
4. Townsend C, Bakewell B, Ly JA, et al. The Effect of Preoperative Benzodiazepine Usage on Postoperative Opioid Consumption After Hand Surgery. Cureus. 2022;14(9):e29608.